Anebulo Pharmaceuticals News

Anebulo Pharmaceuticals | 8-K: Current report

Oct 17 19:05

Anebulo Pharmaceuticals | 8-K: Current report

Jul 22 19:06

Anebulo Pharmaceuticals | 8-K: Current report

Jun 18 04:12

Anebulo Pharmaceuticals | 8-K: Current report

Nov 22, 2023 05:01

Anebulo Pharmaceuticals | DEF 14A: Definitive information statements

Oct 30, 2023 21:22

Anebulo Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 20, 2023 05:18

Anebulo Pharmaceuticals | 8-K: Current report

Oct 7, 2023 04:10

Anebulo Pharmaceuticals | 8-K: Current report

Sep 29, 2023 06:17

Anebulo Pharmaceuticals | 8-K: Current report

Sep 5, 2023 20:00

Anebulo Pharmaceuticals | 8-K: Current report

Apr 11, 2023 21:15

Anebulo Pharmaceuticals | 8-K: Current report

Mar 28, 2023 20:01

Anebulo Pharmaceuticals | 8-K: Current report

Mar 8, 2023 21:00

Anebulo Pharmaceuticals | 8-K: Current report

Jan 9, 2023 21:00

Anebulo Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Nov 3, 2022 04:06

Anebulo Pharmaceuticals | 8-K: Current report

Oct 29, 2022 04:05

Anebulo Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations

Oct 26, 2022 05:27

Anebulo Pharmaceuticals | DEF 14A: Definitive proxy statements

Oct 17, 2022 21:00

Anebulo Pharmaceuticals | 8-K: Current report

Oct 14, 2022 04:05

Anebulo Pharmaceuticals | 8-K: Current report

Sep 30, 2022 04:05

Anebulo Pharmaceuticals | 8-K: Current report

Sep 26, 2022 20:00